The JAK2V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders.
Wappl
Michaela
M
Jaeger
Eva
E
Kusec
Raiko
R
Schwarzinger
Ilse
I
Geissler
Klaus
K
Oehler
Leopold
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000201:enzymology / Q000235:genetics* / Q000401:mortality; D012016:Reference Values; D015996:Survival Rate
C507924:JAK2 protein, human; D053614:Janus Kinase 2